Cryo-Cell International Inc. (CCEL)
NYSE · Healthcare
Cryo-Cell International Inc. Operating Income 2010–2025
Cryo-Cell International Inc. annual/quarterly operating income history and growth rate from 2010 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Cryo-Cell International Inc. operating income for the quarter ending February 28, 2026 was 765134, a 27.54% decrease year-over-year.
- Cryo-Cell International Inc. operating income for the twelve months ending February 28, 2026 was 5.2 M, a 9.46% increase year-over-year.
- Cryo-Cell International Inc. annual operating income for 2025 was 482394, a 86.14% decrease from 2024.
- Cryo-Cell International Inc. annual operating income for 2024 was 3.5 M, a 128.29% decrease from 2023.
- Cryo-Cell International Inc. annual operating income for 2023 was -12.3 M, a 405.73% decrease from 2022.
- Cryo-Cell International Inc. annual operating income for 2022 was 4.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cryo-Cell International Inc. Operating Income — FAQ
Cryo-Cell International Inc. (CCEL) operating income over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
What is Cryo-Cell International Inc.'s operating income?
Cryo-Cell International Inc. (CCEL) reported operating income of $482,394 for fiscal 2025.
Where can I see CCEL's operating income history?
The chart and table above show Cryo-Cell International Inc.'s operating income by year and by quarter, including the growth rate.